Swiss-governed market entry and distribution for healthcare companies in Eastern Europe, the Caucasus, and Central Asia

Delta Medical helps international pharmaceutical, medical device, FSMP, nutraceutical, and consumer health companies register, launch, distribute, and grow their products in markets that are commercially attractive and operationally demanding.

We pair Swiss contracting and quality governance with local teams in regulatory affairs, medical affairs, field promotion, pharmacovigilance, importation, and GDP-compliant distribution. We operate in markets including Armenia, Azerbaijan, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Mongolia, Tajikistan, Turkmenistan, Ukraine, and Uzbekistan.

Discuss a market-entry plan

More about Delta Medical

Why manufacturers choose Delta Medical

Manufacturers use Delta Medical when a market is worth entering but a full local affiliate is not. One partner covers registration, medical affairs, field promotion, pharmacovigilance, importation, and distribution, run by Delta’s own local teams that know each market’s regulators, wholesalers, pharmacy chains, hospitals, and prescribers.

You contract once with DMPAG in Zurich and settle in CHF, USD, or EUR, with no local CIS currency exposure. Our operations are licensed in Switzerland and Ukraine, backed by an FCPA legal opinion, daily sanctions screening, and audits by 14 partners since 2021.

Delta has operated through 50+ months of full-scale war in Ukraine with zero product, transit, or cold-chain losses, including 184 EU-to-Kyiv truck deliveries in 2025 with no cargo lost.

Unloading products to the Delta Medical warehouse

Distribution and supply chain

GDP-compliant distribution that connects manufacturers to 21,000+ pharmacies and 2,150+ hospitals and clinics across 12 markets. Climate-controlled storage, temperature monitoring, and shipment tracking, from the manufacturer to the pharmacy shelf.

Registration and market access

Registration for pharmaceuticals, biologics, medical devices, FSMPs, supplements, disinfectants, and cosmetics. Since 2000, our regulatory teams have supported 436+ medicine and device approvals, handling dossiers, labeling localization, renewals, and variations to remove avoidable delays.

Commercialization and promotion

300+ field specialists in medical and pharmacy teams engage physicians and pharmacists directly, supported by KOL programs, congress activity, and consumer campaigns for OTC and consumer health products where local rules permit.

Commercialization and promotion

For 25+ years, Delta Medical has built local demand for healthcare products across Eastern Europe, the Caucasus, and Central Asia. Manufacturers get one coordinated commercial team in place of separate agents in each country: therapeutic business units, medical representatives, pharmacy teams, product managers, and medical science liaisons working to a single plan.

Ask a Question

Multichannel Promotion:

Our 300+ field specialists form one of the larger dedicated healthcare sales forces in the region. They run compliant medical education and detailing programs that support appropriate prescribing, backed by digital channels, remote detailing, email, and television campaigns for OTC and consumer health products.

In Q1 2026, independent PromoTest data ranked Delta Medical number one in Ukraine for medical representative visits and number two across all pharmaceutical promotional channels. In 2025, our teams delivered 438,000+ HCP engagements at 465 scientific events across 128 cities.

Analytics and Insights:

Market research, HCP feedback, and share-of-voice tracking inform local messaging and brand planning.

CRM activity data, sales performance, and campaign measurement show what is working and where to adjust field effort by territory and by brand.

Flexible Commercial Models:

We work as a contract sales organization, a full-service commercial partner, or a hybrid, depending on the product, the brand stage, and how much local infrastructure you already have.

The same structure can carry an originator specialty launch and a consumer health brand.

Demand Generation:

Our commercial services cover brand management, disease-awareness programs, medical affairs, telemarketing and telesales, e-detailing, and digital demand generation.

Consumer marketing of OTC medicines is a core strength, run within each market’s advertising rules.

GDP-compliant distribution and supply chain

Delta Medical runs GDP-compliant distribution for specialty pharmaceuticals, orphan drugs, consumer medicines, and medical devices across 12 markets in Eastern Europe, the Caucasus, and Central Asia.

Our network reaches 21,000+ pharmacies, 2,150+ hospitals and clinics, and 1,400+ cosmeceutical outlets, with direct-to-pharmacy delivery that reduces reliance on wholesalers. Over $15 million is invested in GDP-certified facilities and delivery fleet across the region.

Ask a Question

Quality Assurance:

Our climate-controlled facilities and delivery fleet operate to ISO 13485 and ISO 22000, alongside GDP and GxP procedures, under a Swissmedic distribution license.

Temperature-sensitive products are handled across cold-chain, controlled room temperature, and ambient ranges, with documented procedures for deviations and excursions that partners can audit.

Delivery across the region:

With 25+ years of specialty distribution in the region, we manage importation, customs clearance, warehousing, and order processing across 13,000+ m2 of facilities, completing thousands of on-time deliveries every day.

Data and Visibility:

Our online portal gives partners order tracking and inventory visibility, with demand forecasting and shipment monitoring that keep stock levels right and flag risks early. For manufacturers, that means wide regional coverage, audited quality, and dependable delivery of their products.

Medical affairs and scientific engagement

Delta Medical has medical-affairs depth across complex disease areas and advanced therapies, including genetics, immunology, nephrology, and oncology. Our teams give healthcare professionals the scientific and clinical information they need on appropriate patient selection and use, within local compliance rules.

Ask a Question

healthcare professional training conference organized across Central Asian markets

Continuous medical education

We run medical education programs and trainings for healthcare professionals on disease areas, products, and new developments in clinical practice.

Recent examples include a Gynecologists’ School on iron deficiency anemia in Tashkent and participation in a national hepatitis B and D conference in Bishkek alongside the Ministry of Health and patient groups.

Early access programs

We design and run pre-approval expanded access programs, compassionate use, and named-patient supply, so novel treatments can reach the patients who need them most before full local approval.

Medical information specialist responding to healthcare professional inquiries and scientific information requests

Responding to medical inquiries

Across scientific exchange and medical-information inquiries, our responses meet local regulatory requirements while giving healthcare professionals accurate, timely answers.

Delta Medical by the numbers

25+

years in the region

700+

team members

300+

field specialists

markets served

Top-6

in Ukraine by pharmaceutical sales (FY2025)

21,000+

pharmacies

2,150+

hospitals and clinics

96+

brands

50+

manufacturing partners

436+

approvals supported since 2000

50+

months operating through the war with zero product losses

438,000+

HCP engagements at 465 events (2025)

Regulatory affairs and market access

Delta Medical’s regulatory and market-access teams work the submission pathways across Eastern Europe, the Caucasus, and Central Asia. Since 2000, we have supported 436+ medicine and device approvals and authored 4,500+ pages of regulatory documentation with our partners.

Ask a Question

Local market-entry strategy:

Early in development, we advise on regulatory feasibility, product classification, labeling requirements, and clinical trial placement, so the market-entry plan is set before submission and avoidable delays are designed out.

Registration management:

We prepare and submit dossiers, manage the review process with local authorities, and maintain registrations after approval, including renewals and variations. Labeling and translation cover 14 regional languages.

Pharmacovigilance:

Our pharmacovigilance teams handle continuous safety monitoring, aggregate safety reporting, and risk-management-plan updates across the product lifecycle, meeting local PV obligations in every market we serve.

Market access and reimbursement:

We advise on positioning, health-economic evidence, and HTA submissions to support national and institutional formulary decisions and pricing negotiations after approval. Closing line: Together, these services give manufacturers one compliant route to market across the region, from classification through reimbursement.

Manufacturers we work with

International healthcare manufacturers across specialty and prescription medicines, consumer health, dermatology, nutrition, FSMP, and medical devices work with Delta Medical for regional registration, promotion, and distribution.

Manufacturers we work with